Actually noting much to update, company is willing to give good return. Just let it flow. the 70c level seems intacted.
Healthcare-related counters everywhere moving up strongly. Take for instance, biolidics in sgx surged almost 4x in 2weeks for its RTK. Local gloves moved up strongly. Other HC related are still still high despite yest's sell off
Copper which is one the main ingredient are going lower.. together with oil gluts.. So, operating expenses should be reduced as well.. same goes to gloves related and plastic related industries as resin price is in discount.
Edwards Lifesciences Q1 2020 results just out from oven.
Critical Care sales were $183 million for the quarter. This performance was lifted by strong demand for the company's disposable pressure monitoring devices used in intensive care units as a result of the COVID-19 pandemic.
This confirms Scomnet production capacity surge to cope with demand. Sources indicate the volume surge is of 5x to 6x. Ready to fly!
Actually that Gilead news is obviously a fake bull news. Any healthcare provider will know that drugs take a much longer time to go through trials (3 phases of trials and then only FDA approval). Even if it is proven effective, it still needs to be studied for human safety purpose and to look for drug interactions (eg you don't want a drug that cures Covid but causes irreversible kidney damage after 2 years). So I would say a cure is at least 1 year away.
Social distancing will be a norm for the next few months. Just assume that from now on you cannot be in a crowd. Hence any retail or tourism related sectors....business will be affected.
As for whether this counter is a buy or sell, please do your own research.
What I'm also saying is that even if MCO is lifted, Covid will still be around. Mco is not meant to totally eradicate covid. It is to flatten the curve.
In a world with social distancing and no mass gathering, what products would you use more? These are the companies that will benefit the most.
What products or services or places would you use or go less? These companies will be in for a hard time. Eg would you go to a casino or concert after this mco when covid could resurface any time?
Top 23 shareholders own 86.18% of the company Jong-Zone Shiue 31.4% Huei-Chung Wu 14.38% Chung-Jung Wu 11.09% Chih-Yu Hsueh 10.8% Lim Chuan 7.02% PMB Investment Berhad 2.02% Sai Mun Chee 1.76% Pacific Rotary Sdn. Bhd. 0.84% Mei-Hsin Liu 0.81% Ling-Miao Liu Kuo 0.81% Shou-Lun Liu 0.81% Wai Sim Ng 0.78% Shu-Li Ho 0.53% Cheng-Chun Chen 0.47% Chin Kiong Too 0.42% Hung Thiam Lim 0.38% Chao-Chih Lee 0.35% Wai Kong Wong 0.29% Boon Tiam Lian 0.28% Wai Lam 0.28% Kok Ping Lee 0.23% Mooi Choo Low 0.22% Li Lian Tan 0.21%
you're right about them being a supplier to edward life sciences. the gem in scomnet lies in smp, their ctos report shows good profit margins. pressure transducers and ecg leads would be of high demand in the ICUs due to the Covid19 outbreak and are single use items which are disposed after each patient.
Scomnet's big customer just announced very good Q2 results.
Ambu posted organic growth of 24% in Q2 as COVID-19 pandemic increased the demand for single-use devices. As a result, Ambu grew 19% in the first half of the year. Product launches for this year are progressing as planned, Ambu’s application for FDA-approval of the duodenoscope has been submitted, and further investments in the global sales organization are initiated. Full-year guidance for organic growth is lifted from “16-22%” to “26-30%” as already announced, and EBIT margin guidance for the full-year is resumed at 12-14% including commercial investments.
What is the amount of endoscope sales over total revenue? is Supercommal the only vendor for Ambu & Edward Lifesciences' endoscopes? Anyone got the data?
"Sales of single-use endoscopes reached 313,000 units for the quarter and 493,000 units for the half-year. Sales volumes were thus up 72% and 49%, respectively, relative to last year."
Ambu forecast sales of 900,000 single-use endoscopes for FY2020. From above Q2 volume was 313,000 and Q1 was 180,000. Based on trajectory, safe to say sales will blow past 1,000,000 units easily.
Thanks for the information. Factors favour this stock: rerating for health stock is huge, the Taiwanese directors meant business, the balance sheet is healthy, and lastly low interest rate is favourable too. I have decided to keep this to see its potential. Your take?
Another interesting article on medical pressure sensors market size.. it's gonna grow significantly! Scomnet is producing pressure transducer devices and patients monitoring devices. Let's wait and see their quarterly results!
Hi Hopeful, Ambu results are not specific enough. I meant what are the exact RM sales revenue in scomnet Quarterly/Full yearly report attributed to endoscopes, bronchoscopes etc single use scopes. Their sales are not 100% from AMBU endoscopes, they got other products as well. Another want to know is whether each & every unit of endoscopes sold by AMBU manufactured by Supercomal Medical Products S/B? Same goes to Edward Lifescience.
If you Google Search Disposable Endoscope Market Growth, you can see various reports about this topic:
Disposable Endoscopes Market Value to Hit US$ 3.1 Bn by 2026 The global disposable endoscopes market value is expected to hit $3.1 billion by 2026 and projected to rake 27.1% CAGR during the forecast period 2018 to 2026 - Acumen Research and Consulting
Healthcare Market Desk Disposable Endoscopes Market Size, Share and Forecast 2019-2027 Press release • Nov 23, 2019 12:39 EST The global disposable endoscopes market size is expected to reach USD 3.31 billion by 2027 and is expected to expand at a CAGR of 29.2% over the forecast period 2019 to 2027.
Disposable Endoscopes Market Share Insights Boston Scientific Corporation, Inc.; Flexicare Medical Ltd; Ambu A/S; Hill Rom Holdings.; and OBP Medical Corporation are the major players operating in this market. New product developments to cater to the multiple application areas is the most notable strategy adopted by these market participants. Of all the market participants Ambu A/S is significantly increasing its product offering, therefore, in next 3-4 years Ambu A/S is poised become one of the largest market participants.
Just info sharing with other Scomnet followers. Good luck.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Xcalibre
504 posts
Posted by Xcalibre > 2020-04-21 13:59 | Report Abuse
Haha @lancefire and @gemstar talking to themselves who's the same person...